Sexual network | Sensitivity analyses | Total costs (million €) | MOAs | QALYs | Cost/MOA (€) | Cost/QALY (€) |
---|---|---|---|---|---|---|
National network (low Ct prevalence) | Base case result | 15.9 | 1639 | 135 | 9705 | 117 529 |
Preterm delivery | 15.6 | 1652 | 135 | 9416 | 114 963 | |
Chronic pelvic pain | 15.6 | 1869 | 2087 | 8326 | 7456 | |
Lowest utility values | 15.9 | – | 153 | – | 104 058 | |
Highest utility values | 15.9 | – | 102 | – | 155 239 | |
Initial participation 30% | 24.2 | 2482 | 199 | 9746 | 121 604 | |
Urban network (high Ct prevalence) | Base case result | 17.1 | 2148 | 216 | 7980 | 79 239 |
Preterm delivery | 16.7 | 2168 | 216 | 7695 | 77 090 | |
Chronic pelvic pain | 16.7 | 2442 | 2724 | 6843 | 6134 | |
Lowest utility values | 17.1 | – | 251 | – | 68 303 | |
Highest utility values | 17.1 | – | 156 | – | 110 020 | |
Initial participation 30% | 25.1 | 2789 | 267 | 8990 | 93 861 |
Chronic pelvic pain: baseline+chronic pelvic pain; preterm delivery: baseline+preterm delivery.Ct, Chlamydia trachomatis; MOA, major outcome averted (baseline: pelvic inflammatory disease, infertility, ectopic pregnancy and neonatal pneumonia); QALY, quality-adjusted life-year.